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OBJECTIVES We sought to determine whether limited left atrial Maze surgery encircling each of the
pulmonary veins, using cooled-tip radiofrequency (RF) ablation, is as effective as the bi-atrial
approach?
BACKGROUND The original Cox/Maze operation effectively restores sinus rhythm (SR) in patients with atrial
fibrillation (AF). Ablation procedures aimed at eliminating pulmonary vein foci have
produced promising short-term success.
METHODS This was a prospective analysis of patients with chronic AF undergoing open-heart surgery in
addition to the Maze operation, using intraoperatively cooled-tip RF ablation either in the
left atrium alone (group A) or in both atria (group B).
RESULTS Patients in group A (n  21) and group B (n  49) did not differ in terms of their baseline
characteristics. Concomitant open-heart surgical procedures included mitral valve replace-
ment (3 vs. 25), mitral valve plasty (0 vs. 2), mitral and aortic valve replacement (1 vs. 1),
aortic valve replacement (4 vs. 6) and coronary artery bypass grafting (13 vs. 15) in groups A
and B, respectively. Follow-up ranged from 1 to 50 months. The overall cumulative rates of
SR were 82% in group A and 75% in group B, without a statistically significant difference
(p  0.571). Bi-atrial contraction was revealed in 92.3% of patients in SR in group A and in
79.2% in group B. The cumulative survival rates were 90.5% in group A and 77.9% in group
B (p  0.880).
CONCLUSIONS A left or bi-atrial Maze operation using intraoperatively cooled-tip RF ablation can safely be
combined with open-heart surgery. A left atrial Maze procedure seems to be as effective as the
bi-atrial procedure and restores SR in 82% of patients. (J Am Coll Cardiol 2002;39:
1644–50) © 2002 by the American College of Cardiology Foundation
Atrial fibrillation (AF) is often associated with other cardiac
diseases, thus compromising the patient’s clinical outcome.
Restoration of sinus rhythm (SR) with atrioventricular
resynchronization may be difficult in patients with chronic
or permanent AF or other risk factors for AF (1–3).
The Maze procedure as an open-heart surgical approach,
established by James Cox and associates, was found to
effectively restore SR and atrial contraction in patients with
intermittent or chronic AF. During the original procedure,
linear lesions in the right and left atria were produced to
prevent the occurrence of multiple reentrant wavelets iden-
tified during AF (4–12). This original Maze operation is
extensive and time-consuming and requires great surgical
skill. In contrast, more recently, Haı¨ssaguerre et al. (13) and
Chen et al. (14) showed that the origin of AF may be
confined to rapidly firing foci of the pulmonary veins.
Transvenous catheter ablation techniques have shown
promising short-term results when ablating or isolating the
pulmonary vein foci (15–17).
In our study, we employed two major modifications to
facilitate the original Maze procedure: cooled-tip radiofre-
quency (RF) ablation was used to perform electrophysi-
ologically transmural linear lesions, and the number of
lesions was minimized by confining the procedure to the left
atrium only. The efficacy of augmenting open-heart surgery
with the modified Maze procedure only in the left atrium,
using cooled-tip RF ablation, in patients with AF was
evaluated, and the outcomes were compared with those of
patients who had bi-atrial Maze surgery.
METHODS
This study was conducted as a prospective, nonrandomized
analysis. The primary end point of our study was the
occurrence of SR during postoperative follow-up. The
secondary end points included survival, adverse events and
atrial transport function.
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Patients. Between March 1997 and February 2001, all
patients undergoing a combination of open-heart surgery
and the modified Maze procedure, using intraoperatively
cooled-tip RF ablation, were included. Written, informed
consent was given by all patients before their inclusion into
the study. All patients had at least one year of chronic or
permanent AF or unsuccessful direct-current shock cardio-
version six months before inclusion.
Surgical procedure. All surgical procedures were per-
formed in the Clinic of Cardiothoracic Surgery, “Berg-
mannsheil” University Hospital, Bochum, Germany. The
additional Maze procedure was performed using cooled-
tip RF ablation. According to the site of ablation,
patients were prospectively assigned to one of two groups:
group A had left atrial ablation only, with ablation lines
around each pulmonary vein’s ostium, interconnections
between the ostial lines and connecting lines to the mitral
valve annulus and left atrial appendage; and group B had
bi-atrial RF ablation, as previously described by Khargi et
al. (18), with ablation lines in the right and left atria.
Ablation lines in the left atrium did not differ between
groups A and B (Fig. 1).
Follow-up. Postoperative follow-up was performed in the
Department of Cardiology, “Bergmannsheil” University
Hospital. Follow-up was performed on postoperative days 1
and 12 and after 3, 6 and 12 months, and then yearly. Some
patients were also seen one month postoperatively. The
anti-arrhythmic drug was sotalol (80 mg twice daily) for at
least six months, up to April 1999. Then, drug treatment
was switched to metoprolol succinate in an equipotent
dosage (at least 47.5 to 95 mg/day).
At each follow-up visit, a clinical history and electrocar-
diogram were obtained. Sinus rhythm was defined as a
supraventricular rhythm with P waves detectable on the
standard 12-lead electrocardiogram. Holter monitoring was
performed six months postoperatively.
After six months, echocardiography was performed, in-
cluding transmitral and transtricuspid Doppler echocardi-
ography. Detection of E and A waves was considered as
atrial contraction.
All data were collected between March 1997 and Febru-
ary 2001.
Statistical analysis. Continuous variables are expressed as
the mean value SD. The Student unpaired t test was used
for comparison of variables between the two groups. Dif-
ferences were considered statistically significant at p 0.05.
The survival rates and cumulative rates of SR were
calculated according to the Kaplan-Meier method, and the
groups were compared using the log-rank test, with a
statistically significant difference assumed at p  0.05.
Abbreviations and Acronyms
AF  atrial fibrillation
RF  radiofrequency
SR  sinus rhythm
Figure 1. Schematic view of the ablation pattern (dotted black lines) in the left atrium; surgical access was through the Waterstone Grove. The encircling
ablation lesions around each pulmonary vein’s ostium and the interconnecting lines, as well as additional lines to the mitral valve (MV) annulus and the
excision of the left auricle (LA), are shown. LIPV  left inferior pulmonary vein; LSPV  left superior pulmonary vein; RIVP  right inferior pulmonary
vein; RSPV  right superior pulmonary vein.
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RESULTS
Seventy patients were included during the study period and
had completed at least one month of follow-up. Group A
consisted of 21 patients and group B of 49 patients. The
patients did not differ in terms of their baseline character-
istics (age, duration of AF before surgery, left atrial dimen-
sions and preoperative ejection fraction) (Table 1). All
patients had an indication for open-heart surgery, indepen-
dent AF. Concomitant procedures performed in groups A
and B included mitral valve replacement (3 vs. 25), mitral
valve plasty (0 vs. 2), combined mitral and aortic valve
replacement (1 vs. 1), combined mitral valve replacement
(4 vs. 2), aortic valve replacement (4 vs. 6) and aorto-
coronary bypass grafting (13 vs. 15) (Table 1).
Follow-up. All 70 patients completed at least one month
of follow-up. The duration of follow-up ranged from 4 to 20
months (mean 11  10) in group A and 1 to 50 months
(mean 18  14) in group B, with statistically significant
longer follow-up durations in group B (p  0.05).
In group A, 19 patients completed three months of
follow-up; 17 patients completed six months; and 7 patients
completed 12 months. In group B, 39 patients completed
three months of follow-up; 36 patients completed six
months; 29 patients completed 12 months; 21 patients
completed 24 months; 7 patients completed 36 months; and
2 completed 48 months.
Cardiac rhythm. The cumulative rates of SR for complete
follow-up were 82% (17 of 21 patients) for group A and
75% (34 of 49 patients) for group B, without a statistically
significant difference (p  0.571). The cumulative rates of
SR evolved during follow-up in the two groups (group A vs.
group B): at one month, 63% vs. 55%; at three months, 82%
(16 of 19 patients) vs. 65% (26 of 39 patients); and at six
months, 82% (14 of 17 patients) vs. 68% (24 of 36 patients).
Only one patient in group B converted to SR more than six
months after the procedure (at 24 months) (Fig. 2).
With completed follow-up in groups A and B, 16 of 21
patients and 34 of 49 patients, respectively, were in SR. The
Table 1. Baseline Patient Characteristics and Surgical
Procedures
Group A
Left Atrial Maze*
(n  21)
Group B
Bi-Atrial Maze*
(n  49) p Value
Age (yrs) 69  9 65  9 0.118
LA dimension (mm) 47  8 51  10 0.224
Ejection fraction (%) 56  10 59  10 0.453
AF duration (yrs) 13  17 9  8 0.538
Range 1–25 1–15
Follow-up (months) 11  10 18  14 0.046
Range 4–20 1–50
MVR 3 25
MVP 0 2
MVR  AVR 1 1
AVR 4 6
ACB ( MVR) 13 (4) 15 (2)
*In addition to anti-arrhythmic surgery. Data are presented as the mean value  SD
or number of patients.
ACB  aorto-coronary bypass surgery; AF  atrial fibrillation; AVR  aortic
valve replacement; LA  left atrial; MVP  mitral valve plasty; MVR  mitral valve
replacement.
Figure 2. Cumulative rates of sinus rhythm during postoperative follow-up (group A  left atrial Maze procedure; group B  bi-atrial Maze proce-
dure).
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mode of conversion to SR was spontaneous in all patients in
group A and in all but one patient (who had long-term
success after direct-current shock cardioversion) in group B
in SR (97% of all patients). Of the 15 patients still in AF in
group B, 12 were electrically cardioverted (direct-current
shock), with an immediate success rate of 27% (3 of 11
patients were in SR immediately after cardioversion); long-
term success (SR at next follow-up visit) was achieved in
only one patient (9.1% of cardioverted patients). No patient
from group A was converted using direct-current shock.
Overall, only 1 of the 12 patients who were cardioverted was
converted to prolonged SR (8%).
One patient from group B converted from SR to AF 12
months postoperatively, when sotalol was replaced by meto-
prolol. After re-institution of sotalol, medication-stable SR
was re-established.
Two patients from group B demonstrated atypical atrial
flutter between one and three months of follow-up: one
patient was converted to SR while increasing the sotalol
dosage from 80 to 160 mg twice daily. In the other patient,
catheter ablation was performed in the right atrium, closing
a gap between the intercaval intraoperative ablation line and
the upper caval vein. Long-term, stable SR was found after
the procedure in both patients.
Holter monitoring revealed short runs of atrial tachycar-
dia (15% of the Holter interval) in two patients in SR in
group A (12.5%) and 5 patients in group B (14.7%).
Doppler echocardiography. In groups A and B, 13
(81.3%) of 16 patients and 24 (70.6%) of 34 patients in SR,
respectively, underwent Doppler echocardiography. Bi-
atrial contraction was documented during transthoracic
Doppler echocardiography in 12 of 13 patients in SR in
group A (92.3%) and in 19 of 24 patients in SR in group B
(79.2%). In group A, all of the patients in SR had docu-
mented right atrial contraction (100%). In group B, two
patients (1 patient after 3 months and 1 patient after 6 months)
had no detectable right atrial contraction on the transthoracic
echocardiogram (92% with right atrial contraction).
Pacemaker indication and complications. Two patients
in group B (4%) had permanent pacemakers implanted
because of postoperative bradycardia (1 patient with DDD
and 1 with VVI pacemaker). Implantation was performed
during one to three months postoperatively. No patient in
group A had an indication for postoperative pacemaker
implantation.
Bleeding requiring transfusion occurred in three patients
(1 in group A after aorto-coronary bypass grafting plus
mitral valve replacement; 2 in group B [1 had renal bleeding
with a lethal outcome after mitral valve replacement and 1
had gastrointestinal bleeding after aortic valve replace-
ment]), all under standard anticoagulative therapy, as used
after valve replacement. Pericardial effusion occurred in one
patient in group A and in two patients in group B, without
the need for further invasive therapy. Two patients in each
group (1 after aorto-coronary bypass grafting and 1 after
aortic valve replacement in group A and 2 after mitral valve
replacement in group B) had transitory neurologic symp-
toms in the first days after the surgical procedure.
Duration of the surgical procedure. The mean bypass
duration was 146  34 min in group A and 179  35 min
in group B (p  0.05). The mean aortic clamp duration was
98 24 min in group A and 101 20 min in group B (p
0.53), showing a shorter duration in the group of patients
with only the left atrial Maze operation.
Survival. The cumulative survival rates were not statisti-
cally significant different between the two groups (90% in
group A vs. 78% in group B; p  0.880) (Fig. 3). Two
patients in group A died within 30 days after the operation:
1 patient died of mediastinitis 21 days postoperatively, and
1 died of postoperative severe pyoderma with sepsis after 28
days. In group B, six patients died during follow-up: one
patient died 40 days postoperatively, due to renal bleeding;
one died after 45 days, due to mediastinitis; one had sudden
cardiac death after four months; one had progressive respi-
ratory insufficiency at seven months; one had respiratory
insufficiency at 16 months; and one died of an unknown
cause (noncardiac or cerebral ischemia) after 33 months.
DISCUSSION
To the best of our knowledge, this study is a first analysis of
data obtained in patients undergoing a modified Maze
procedure in addition to another open-heart surgical pro-
cedure, comparing the left atrial approach with the bi-atrial
Maze operation.
Background. The left atrial only approach was considered,
based on the study findings of Haı¨ssaguerre et al. (13), who
documented focal ectopies arising from the pulmonary
veins, thus inducing paroxysmal AF. This mechanism was
also considered to maintain permanent and/or persistent AF
and may be stopped when ablating or isolating foci of the
pulmonary veins. Sueda et al. (19) proposed a minimized
left atrial approach for patients with mitral valve disease and
documented left atrial foci during intraoperative AF map-
ping, with promising results regarding SR in 86% (13–
16,19–21).
These findings lead to the concept of approaching the left
atrium only during anti-arrhythmic surgery. In addition to
isolating each of the four pulmonary vein’s ostia, an inter-
connection of the ablation line circles was performed,
including additional ablation lines connecting the mitral
valve annulus to the left atrial appendage.
Efficacy of the limited left atrial anti-arrhythmic proce-
dure. This study was conducted to evaluate the efficacy and
safety of the left atrial only approach during anti-arrhythmic
surgery. In our experience with 70 patients, we retrospec-
tively compared the outcomes of patients undergoing left
atrial–only Maze surgery, using intraoperatively cooled-tip
RF ablation, with the outcomes of patients undergoing
bi-atrial Maze surgery, again using the RF ablation tech-
nique. Restoration of SR was documented in these patients,
with a long duration of AF before the operation and large
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left atrial dimensions in 81.6% of patients after the left
atrial–only ablation procedure. Compared with patients
undergoing bi-atrial ablation, who obtained SR at a rate of
74.5%, there was no statistically significant difference. These
data are comparable to the results documented by different
groups (5,7,8–11,22,23), who found restoration of SR
between 72% and 99%, depending on the surgical procedure
used and the patient cohort (e.g., concomitant underlying
heart disease, idiopathic AF). Melo et al. (22) proposed a
pulmonary vein isolation technique with one incision encir-
cling the four pulmonary veins, producing SR with bi-atrial
contraction in only 33% of the patients after one year.
One-third of the patients remained in AF after this proce-
dure. The left atrial approach we proposed, encircling each
of the four pulmonary vein ostium, seems to produce a
higher rate of SR.
Failure of the anti-arrhythmic procedure. The mecha-
nisms for failure of the left atrial–only procedure still need
to be investigated. On the one hand, there may be gaps in
the ablation lines, causing recurrent reentry circles, or on the
other hand, the origin of the arrhythmia was not in the left
atrium, as proposed to be the case in 9% to 19% of patients
with underlying mitral valve disease. The mechanism of AF
may be different in terms of the underlying heart disease.
Patients with right atrial foci should benefit from the
bi-atrial approach, even though there is no higher rate of SR
in these patients, as documented in our study. Further
evaluation using modern electroanatomic mapping systems
may be helpful in understanding the mechanisms in patients
with failure (19,20,24).
Atrial function after anti-arrhythmic surgery. An impor-
tant aim of restoring SR is to produce atrial contraction of
both atria, to restore atrioventricular electromechanical
synchrony and to decrease the risk of cardiac thromboem-
bolism. In our study, bi-atrial contraction was restored in
92.3% of patients in SR after the left atrial approach and in
79.2% of patients in SR after the bi-atrial Maze operation.
The outcome of these patients can be defined as complete
success (score 4), when applying the Santa Cruz scoring
system initiated by Melo et al. (22). The difference between
the two groups may be the result of the fewer patients with
mitral valve disease in the group undergoing left atrial
incisions only, who seem to have a poorer prognosis for SR
restoration and larger atrial dimensions. In contrast, the
higher rate of effective bi-atrial contraction may be attrib-
uted to the minimized procedure itself. A smaller atrial area
was isolated (preventing contraction), which may lead to more
completely contracting atrial tissue (22). The left atrial inci-
sions and ablation lines were the same in both groups. Our data
are equivalent to the published data that document the occur-
rence of bi-atrial contraction in 66.7% to 99% of patients.
Again, the results differ in terms of the applied surgical
procedure and the baseline characteristics of the patients (22).
The rates of left atrial contraction may be underestimated
by transthoracic echocardiography. Cox (4) proposed that
left atrial contraction can more often be demonstrated by
transesophageal echocardiography, compared with trans-
thoracic echocardiography. The question remaining is
whether patients without documented left atrial contraction
(during transthoracic or transesophageal echocardiography)
Figure 3. Cumulative survival of patients during postoperative follow-up (group A  left atrial Maze procedure; group B  bi-atrial Maze procedure).
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should be anticoagulated, and to what extent (anticoagula-
tion plus antithrombotic medication?).
Safety of intraoperatively cooled-tip RF ablation. The
safety of adding the modified Maze operation (either left
atrial or bi-atrial), as proposed in our study, can be derived
from the low 30-day mortality and low complication rates.
Two patients died within the first 30 days after the
operation, and another death due to mediastinitis after 45
days might be associated with the anti-arrhythmic proce-
dure added to the surgical procedure. Although these
mortality rates are not higher than those associated with
open-heart surgery, without additional anti-arrhythmic pro-
cedures, a mediastinal infection might become an acute
postoperative complication. Antibiotic treatment and repeat
operations have a high rate of failure, so that prevention by
minimizing the procedure’s duration (or limiting the num-
ber of ablation lines) should be anticipated.
Our data are comparable to those published by different
investigators, but again, the differing patient characteristics
must be accounted for (5,7–11). Adding the anti-
arrhythmic procedure to another open-heart operation may
lead to higher mortality, even though there was no signifi-
cant difference seen in a randomized study of patients
undergoing mitral valve replacement with or without the
Maze procedure (Deneke et al. [25]). This needs to be
analyzed in further prospective, randomized studies includ-
ing larger patient cohorts.
We found a shorter bypass time and aortic clamp duration
in patients who received ablation in the left atrium only, which
can be attributed to the shorter procedure, as it was restricted
to one atrium. The bypass time was not significantly different
between the two groups, because of the need for cardiopulmo-
nary bypass for blood-free access to the left atrium.
We did not find any adverse events related to the
postoperative care after the left atrial Maze procedure; in
particular, there were no cases of pulmonary vein stenosis
and no indication for pacemaker implantation. Pulmonary
vein stenosis may occur when ablation is done inside the
veins, which is one major drawback of focal catheter
ablation of AF. The approach of encircling each of the
pulmonary vein’s ostia diminishes the risk of this compli-
cation. During our whole experience, two patients received
a permanent pacemaker due to postoperative bradycardia,
which has been reported previously (5,8). Whether the
requirement for pacemaker therapy was due to the Maze
procedure or preoperative sinus node dysfunction cannot be
evaluated. Some of the patients may demonstrate late stages
of sick sinus syndrome, with an indication for pacemaker
therapy, due to this disease itself (5).
Anti-arrhythmic medication after anti-arrhythmic sur-
gery. Still under debate is the appropriate anti-arrhythmic
medication after open-heart surgery and especially after
anti-arrhythmic surgical procedures. Although Cox et al. (5)
studied a high number of patients who received no anti-
arrhythmic drug therapy postoperatively (94%), this may
only be possible in patients with idiopathic AF. It has been
widely established that sotalol should be administered in the
early postoperative period, but it is less clear what to do in
the long term. In the beginning of our experience, we
treated patients with sotalol for at least six months (26).
Cardioversion after anti-arrhythmic surgery. Another
descriptive finding is the low long-term efficacy of electric
cardioversion in patients who have undergone anti-arrhythmic
surgery. Only 50% of overall patients with AF agreed to
direct-current cardioversion in the first six months after the
operation. Only one patient had long-term success (9%),
despite a rather aggressive cardioversion protocol. From this
finding, we derived a stepwise action plan for these patients: all
patients were put on metoprolol therapy, and spontaneous
conversion was awaited during the first six months after the
operation. Only if patients were still in AF for more than six
months after the anti-arrhythmic surgery was direct-current
shock cardioversion anticipated once during follow-up.
Study limitations. Our study was a retrospective analysis of
a rather small number of patients. Randomization was not
performed, but the two groups showed no statistically
significant difference in terms of their baseline characteris-
tics. This analysis was performed in patients over almost
four years, during which time the device used to perform the
cooled-tip RF ablation lines was changed twice, even
though the pattern of the ablation lines was kept the same.
This may have effects on the efficacy of the procedure,
especially when considering that patients in group A were
underwent the operation in the later phase of the observa-
tional period.
Conclusions
1. A left atrial anti-arrhythmic procedure establishing linear
lesions encircling each ostium of the pulmonary vein,
using cooled-tip RF ablation, can restore SR in patients
with chronic AF.
2. Left atrial Maze surgery using intraoperative RF ablation
can safely be combined with other open-heart surgical
procedures and restores SR as effectively as the bi-atrial
approach (in 81.6% of patients in chronic AF).
3. Bi-atrial contraction can be restored after the left atrial
Maze procedure in 92.3% of patients in SR.
4. Direct-current shock cardioversion seems to show low
long-term efficacy in patients who have undergone the
Maze operation.
Larger prospective, randomized trials that can evaluate
the left atrial-only approach for anti-arrhythmic surgery, as
well as detect patients with a poorer prognosis for stable SR,
are needed before this procedure can be universally accepted.
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